CareTria acquired CaryHealth to build an AI direct-to-patient pharmacy platform focused on reducing friction between prescribing and therapy initiation. The combined offering merges CareTria’s therapy initiation services with CaryHealth’s AI-powered digital pharmacy and patient-engagement technology. The platform is designed to automate benefit investigation workflows and speed up case completion, with CareTria reporting many cases are resolved in under 60 seconds. It also supports multiple fulfillment pathways, including cash payment and starter doses, alongside commercial pharmacy dispensing across the US. CareTria said the integration aims to connect telehealth onboarding, benefit investigation, patient communications, and dispensing into a unified system to limit patient drop-off during coverage disruptions. For biotech partners and sponsors, the operational push signals growing emphasis on real-world adherence and access mechanics—not just clinical efficacy—especially for specialty therapeutics with complex payer workflows.